Gregory Benne

Gregory Benne is a seasoned finance professional currently serving as the Global Business Controller for the RDMA Unit at Sobi - Swedish Orphan Biovitrum AB since November 2019. With a focus on research, development, and medical affairs, Gregory leads global financial operations, coordinates forecasting cycles, and partners with senior management to provide financial guidance and enhance decision-making across legal entities. Previous experience includes roles as Financial Controller at Sobi for Immunology/Rare Disease, Boehringer Ingelheim for the Animal Health Division, and Sanofi in the R&D Division, where Gregory consistently exceeded performance expectations. Gregory holds an Executive Master of Business Administration from EDHEC Business School, along with a finance specialization degree from the same institution and has participated in an Erasmus Exchange Program in finance at ISM University of Management and Economics.